Formulation: A lyophilized powder
Formal Name: 6-oxo-9α,11α,15S-trihydroxy-2,3-dinor-prost-13E-en-1-oic 15,15,16,16,17,17,18,18,18-d9 acid, sodium salt
Purity: ≥99% deuterated forms (d1-d9)
Formula Markup: C18H20D9O6 • Na
Formula Weight: 373,5
Shelf life (days): 365
Notes: An internal standard for the quantification of 2,3-dinor-6-keto Prostaglandin F1α by GC- or LC-MS. 2,3-dinor-6-keto prostaglandin F1α (2,3-dinor-6-keto PGF1α) is the β-oxidation product of 6-keto PGF1α and the major urinary metabolite of PGI2 in humans.{438,440} 2,3-dinor-6-keto PGF1α makes up 23% of the recovered radioactivity in urine after administration of labeled 6-keto PGF1α and 20.5% after administration of labeled PGI2.{440} In healthy human subjects, the average excreted 2,3-dinor-6-keto PGF1α level is ~100 pg/mg creatinine.{1027}